BioCentury
ARTICLE | Clinical News

Herceptin trastuzumab regulatory update

February 18, 2013 8:00 AM UTC

Chugai said it submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for once-weekly Herceptin trastuzumab as postoperative adjuvant chemotherapy to treat breast cancer that overexp...